Download Sample
Add to CartGlobal Virus Filtration Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Technology;
Filtration and ChromatographyBy Product;
Consumables, Instruments, and ServicesBy Application;
Biologicals, Medical Devices, and Water PurificationBy End-User;
Hospitals & Clinics, Pharmaceutical Companies, Medical Device Companies, Contract Testing Organizations, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Virus Filtration Market Overview
Virus Filtration Market (USD Million)
Virus Filtration Market was valued at USD 5,196.15 million in the year 2024. The size of this market is expected to increase to USD 11,415.43 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.9%.
Global Virus Filtration Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 11.9 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 11.9 % |
| Market Size (2024) | USD 5,196.15 Million |
| Market Size (2031) | USD 11,415.43 Million |
| Market Concentration | Low |
| Report Pages | 375 |
Major Players
- Merck KGaA
- Danaher
- Sartorius AG
- Thermo Fisher Scientific Inc
- GE Healthcare
- Charles River Laboratories
- Asahi Kasei Medical Co Ltd
- WuXi AppTec
- Lonza
- Clean Biologics
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Virus Filtration Market
Fragmented - Highly competitive market without dominant players
The virus filtration market is experiencing steady expansion, driven by the critical need to ensure biopharmaceutical purity and safety. As the production of vaccines and therapeutic proteins increases, filtration solutions are becoming essential to eliminate viral contaminants. Currently, more than 55% of biologics manufacturers employ virus filtration techniques during downstream processing to uphold quality standards.
Surge in Biologic-Based Treatments Boosting Demand
With biologic drugs accounting for over 60% of newly approved therapies, the necessity for effective virus removal is intensifying. These treatments, including monoclonal antibodies and recombinant proteins, require virus filtration as a safeguard step. The growing preference for biologic-based healthcare solutions has made virus filtration indispensable to modern pharmaceutical manufacturing.
Advances in Filtration Technology Supporting Efficiency
Innovations in filter design and membrane materials are driving improvements in virus retention capabilities. Around 40% of filtration systems now utilize advanced nanofiber materials, offering higher precision and throughput. These technological upgrades are not only reducing downtime but also helping manufacturers meet increasing production demands while maintaining product integrity.
Sustained Market Momentum Fueled by Biosafety Priorities
Virus filtration continues to gain momentum as biosafety becomes a core priority in biomanufacturing. Approximately 65% of contract manufacturing service providers now integrate virus filtration as part of their routine offerings. The market is poised for further growth, driven by ongoing research, evolving therapeutic approaches, and heightened safety requirements.
Virus Filtration Market Recent Developments
-
In March 2018, Pall Corporation launched its new division Pall Biotech. The newly launched division will focus on increasing efficiency and quality of biological products, viral vaccines, and virus filtration products.
-
In August 2019, Unilever announced an agreement to acquire Blueair, a considerable player in the air purification technologies and solutions.
Virus Filtration Market Segment Analysis
In this report, the Virus Filtration Market has been segmented by Technology, Product, Application, Product, End-User and Geography.
Virus Filtration Market, Segmentation by Technology
The Virus Filtration Market has been segmented by Technology into Filtration and Chromatography.
Filtration
Filtration dominates the virus filtration market, contributing approximately 74% of global revenue in 2022. This technology is widely used in biopharmaceutical manufacturing for its ability to effectively remove viral contaminants while maintaining product quality. The increasing adoption of single-use technologies and membrane filtration systems drives growth in this segment.
Chromatography
Chromatography holds an estimated 26% share of the global virus filtration market. This technology is used for both viral removal and viral clearance validation in bioprocessing. Its application in plasma fractionation and monoclonal antibody production supports market expansion. Advancements in chromatographic techniques continue to enhance process efficiency and selectivity.
Virus Filtration Market, Segmentation by Product
The Virus Filtration Market has been segmented by Product into Consumables, Instruments and Services.
Consumables
Consumables dominate the virus filtration market, contributing approximately 59% of global revenue in 2022. This category includes filters, membranes, and cartridges used in biopharmaceutical manufacturing and research applications. The growing demand for single-use systems and high-capacity filtration solutions supports this segment’s growth.
Instruments
Instruments hold an estimated 27% share of the global virus filtration market. This segment encompasses filtration systems, chromatography equipment, and automated platforms used to ensure virus removal and process efficiency. Continuous advancements in filtration and chromatography technology fuel demand in this segment.
Services
Services contribute around 14% of the global virus filtration market. These include validation, maintenance, and consulting services provided to support bioprocessing operations. Increasing regulatory requirements and the need for process optimization drive demand for specialized virus filtration services.
Virus Filtration Market, Segmentation by Application
The Virus Filtration Market has been segmented by Application into Biologicals, Medical Devices and Water Purification.
Biologicals
Biologicals dominate the virus filtration market, contributing approximately 67% of global revenue in 2022. This segment includes monoclonal antibodies, recombinant proteins, vaccines, and gene therapy products. The rising demand for biopharmaceuticals and the need for stringent viral clearance processes drive strong growth in this segment.
Medical Devices
Medical Devices hold an estimated 21% share of the global virus filtration market. These include implantable devices and tubing systems that require viral contamination prevention during manufacturing. Increasing adoption of virus filtration technologies in medical device production enhances safety and compliance.
Water Purification
Water Purification accounts for around 12% of the global virus filtration market. Virus filtration is essential for ensuring microbiological safety in pharmaceutical manufacturing and laboratory applications. Growing concerns about waterborne viral contaminants and the need for high-purity water drive this segment’s growth.
Virus Filtration Market, Segmentation by End-User
The Virus Filtration Market has been segmented by End-User into Hospitals and Clinics, Pharmaceutical Companies, Medical Device Companies, Contract Testing Organizations and Others.
Hospitals and Clinics
Hospitals and Clinics contribute approximately 24% of the global virus filtration market revenue in 2022. These facilities require virus filtration solutions for applications such as water purification and the preparation of sterile fluids. Increasing focus on infection control and patient safety drives demand in this segment.
Pharmaceutical Companies
Pharmaceutical Companies dominate the virus filtration market, contributing around 46% of global revenue. These organizations use virus filtration technologies to ensure product safety and compliance during biopharmaceutical manufacturing. Growing demand for biologics and gene therapy products supports strong growth in this segment.
Medical Device Companies
Medical Device Companies hold an estimated 14% share of the global virus filtration market. These companies use filtration systems to prevent viral contamination during the production of implantable devices and other high-risk components. The focus on quality assurance and regulatory compliance supports demand.
Contract Testing Organizations
Contract Testing Organizations contribute approximately 10% of the global virus filtration market revenue. These organizations provide virus clearance testing and validation services for biopharmaceutical companies and medical device manufacturers. The increasing complexity of biologic products and rising outsourcing trends drive growth in this segment.
Others
The "Others" category, including research institutions and academic labs, holds an estimated 6% share of the global virus filtration market. These entities use filtration technologies for scientific research and method development, supporting innovations in virus removal strategies and bioprocessing techniques.
Virus Filtration Market, Segmentation by Geography
In this report, the Virus Filtration Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Virus Filtration Market Share (%), by Geographical Region
North America
North America leads the virus filtration market, accounting for approximately 42% of global revenue in 2022. This region benefits from advanced biopharmaceutical manufacturing infrastructure, strong regulatory frameworks, and the presence of major market players. The rising demand for biologics and gene therapy products further fuels market growth.
Europe
Europe holds around 28% of the global virus filtration market. Growth in this region is supported by increasing investment in bioprocessing technologies, expanding pharmaceutical manufacturing, and strong emphasis on product safety. Collaboration between industry and regulatory bodies enhances regional growth.
Asia Pacific
Asia Pacific accounts for an estimated 20% share of the global virus filtration market. Rapidly improving healthcare infrastructure, rising biopharmaceutical investments, and increasing demand for high-quality biologics drive growth. Countries such as China, India, and Japan are key contributors, fueled by growing clinical research activities and regulatory approvals.
Middle East and Africa
Middle East and Africa contribute approximately 6% of the global virus filtration market. This growth is driven by expanding healthcare access, increasing focus on quality manufacturing, and rising demand for safe therapeutic products. Partnerships with global market leaders strengthen regional market development.
Latin America
Latin America holds around 4% of the global virus filtration market. Growth drivers include rising biopharmaceutical production, increasing adoption of advanced virus filtration technologies, and efforts to improve healthcare infrastructure. Regional initiatives to promote domestic manufacturing further support market expansion.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Virus Filtration Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Demand for Biopharmaceuticals
- Stringent Regulatory Requirements for Viral Safety
-
Advancements in Filtration Technologies - One key driver of advancements in filtration technologies is the growing demand for robust viral clearance solutions in biopharmaceutical manufacturing. As the production of biologics, vaccines, and other biological products continues to expand, there is an increasing need for more effective and efficient virus filtration methods to ensure product safety and regulatory compliance. Manufacturers are investing in research and development efforts to innovate new filtration technologies that can achieve higher levels of viral clearance while minimizing the impact on product integrity and yield.
Advancements in filtration technologies are driven by the need to address emerging viral threats and evolving regulatory requirements. The emergence of new viruses, such as the novel coronavirus SARS-CoV-2, highlights the importance of proactive measures to enhance viral safety in biopharmaceutical production and healthcare settings. In response, researchers and engineers are developing novel filtration techniques, such as nanofiltration, microfiltration, and virus removal membranes, capable of efficiently removing a broad spectrum of viral contaminants while preserving product quality and performance.
Technological advancements in virus filtration are driven by the quest for scalability, cost-effectiveness, and sustainability in manufacturing processes. Manufacturers are exploring innovative approaches, such as single-use filtration systems, disposable filters, and continuous manufacturing platforms, to streamline operations, reduce production costs, and minimize environmental impact. These advancements enable flexible and agile manufacturing processes, allowing companies to adapt quickly to changing market demands and regulatory requirements.
Restraints
- High Cost of Virus Filtration Processes
- Potential Impact on Product Integrity
-
Limited Scalability of Filtration Systems - One of the primary limitations of filtration systems is their capacity to handle high volumes of process fluids while maintaining optimal filtration efficiency and product quality. As biopharmaceutical production scales up to meet commercial demands, the volume of process fluids requiring viral clearance increases exponentially. However, conventional filtration systems may struggle to accommodate these higher volumes without compromising performance or risking filter fouling, which can lead to reduced throughput, longer processing times, and increased operating costs.
The physical size and footprint of filtration equipment pose challenges in large-scale manufacturing facilities where space constraints may limit the installation of additional filtration units. This limitation further exacerbates scalability issues, as manufacturers may be unable to expand filtration capacity to meet growing production demands without significant facility modifications or investments in new infrastructure.
The complexity of filtration processes, including validation requirements, process optimization, and regulatory compliance, adds further challenges to scaling up filtration systems. Achieving consistent and reproducible viral clearance across large-scale manufacturing operations requires stringent process controls, robust quality assurance measures, and comprehensive validation protocols to ensure compliance with regulatory guidelines and product specifications.
Opportunities
- Expansion of Biologics Manufacturing
- Growing Emphasis on Vaccine Development
-
Adoption of Single-Use Filtration Systems - One key opportunity presented by single-use filtration systems is their flexibility and scalability, enabling biopharmaceutical companies to adapt quickly to changing production needs and manufacturing volumes. Unlike traditional filtration setups that require extensive cleaning, validation, and maintenance between batches, single-use filtration systems can be easily deployed and disposed of after use, reducing downtime and speeding up production cycles. This flexibility is particularly valuable in biopharmaceutical manufacturing, where rapid process development, scale-up, and technology transfer are essential for meeting market demand and regulatory timelines.
Single-use filtration systems offer cost-effective solutions for viral clearance and bioprocessing, eliminating the need for capital investment in stainless steel equipment, infrastructure, and cleaning validation procedures. By reducing upfront investment and operating costs, single-use filtration systems enable manufacturers to lower production expenses, improve process economics, and enhance overall operational efficiency. This cost advantage is especially beneficial for contract manufacturing organizations (CMOs) and small to mid-sized biotech companies seeking to streamline their manufacturing operations and accelerate time to market for biologics and vaccines.
Single-use filtration systems offer enhanced product and process safety, minimizing the risk of cross-contamination, product carryover, and viral transmission between batches. Disposable filtration assemblies, including filter capsules, cartridges, and disposable depth filters, provide a closed and sterile environment for viral clearance processes, ensuring the integrity and purity of biopharmaceutical products. This level of containment and sterility is critical for meeting regulatory requirements and maintaining product quality standards in biopharmaceutical manufacturing and vaccine production.
Competitive Landscape Analysis
Key players in Global Virus Filtration Market include:
- Merck KGaA
- Danaher
- Sartorius AG
- Thermo Fisher Scientific Inc
- GE Healthcare
- Charles River Laboratories
- Asahi Kasei Medical Co Ltd
- WuXi AppTec
- Lonza
- Clean Biologics
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End-User
- Market Snapshot, By Region
- Virus Filtration Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Demand for Biopharmaceuticals
-
Stringent Regulatory Requirements for Viral Safety
-
Advancements in Filtration Technologies
-
- Restraints
-
High Cost of Virus Filtration Processes
-
Potential Impact on Product Integrity
-
Limited Scalability of Filtration Systems
-
- Opportunities
-
Expansion of Biologics Manufacturing
-
Growing Emphasis on Vaccine Development
-
Adoption of Single-Use Filtration Systems
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Virus Filtration Market, By Technology, 2021 - 2031 (USD Million)
-
Filtration
-
Chromatography
-
- Virus Filtration Market, By Product, 2021 - 2031 (USD Million)
- Consumables
- Instruments
- Services
-
Virus Filtration Market, By Application, 2021 - 2031 (USD Million)
-
Biologicals
-
Medical Devices
-
Water Purification
-
- Virus Filtration Market, By End-User, 2021 - 2031 (USD Million)
-
Hospitals and Clinics
-
Pharmaceutical Companies
-
Medical Device Companies
-
Contract Testing Organizations
-
Others
-
- Virus Filtration Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Virus Filtration Market, By Technology, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Merck KGaA
- Danaher
- Sartorius AG
- Thermo Fisher Scientific Inc
- GE Healthcare
- Charles River Laboratories
- Asahi Kasei Medical Co Ltd
- WuXi AppTec
- Lonza
- Clean Biologics
- Company Profiles
- Analyst Views
- Future Outlook of the Market